LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
Halozyme Therapeutics
HALO
AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
AIPUY
YETI Holdings
YETI
Dorian LPG
LPG
(Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 6.79%7.02B | -1.73%7.16B | -3.37%6.77B | -2.07%27.75B | -7.16%6.89B | -10.81%6.57B | 5.52%7.29B | 5.42%7B | -9.30%28.34B | -2.39%7.43B |
Operating revenue | 6.79%7.02B | -1.73%7.16B | -3.37%6.77B | -2.07%27.75B | -7.16%6.89B | -10.81%6.57B | 5.52%7.29B | 5.42%7B | -9.30%28.34B | -2.39%7.43B |
Cost of revenue | -4.80%4.02B | -13.34%4.15B | -14.76%4B | -8.22%17.96B | -14.58%4.25B | -14.81%4.23B | -1.09%4.79B | -1.99%4.69B | -10.41%19.57B | -8.07%4.98B |
Gross profit | 27.71%2.99B | 20.54%3.01B | 19.70%2.77B | 11.65%9.8B | 7.93%2.64B | -2.54%2.34B | 21.04%2.5B | 24.46%2.32B | -6.71%8.77B | 11.63%2.45B |
Operating expense | -3.94%1.22B | -8.53%1.15B | -7.57%1.14B | -7.98%4.82B | 2.49%1.07B | -11.76%1.27B | -11.43%1.26B | -8.42%1.23B | -16.73%5.24B | -26.62%1.05B |
Selling and administrative expenses | -3.94%1.22B | -8.53%1.15B | -7.57%1.14B | -9.70%5.02B | -6.98%1.27B | -11.76%1.27B | -11.43%1.26B | -8.42%1.23B | -16.90%5.56B | -25.10%1.36B |
-Selling and marketing expense | 0.46%220M | -0.47%210M | -11.79%187M | -21.59%897M | -4.14%255M | -10.61%219M | -30.36%211M | -35.76%212M | -57.28%1.14B | -64.53%266M |
-General and administrative expense | -4.86%998M | -10.15%938M | -6.69%949M | -6.62%4.12B | -7.67%1.01B | -12.00%1.05B | -6.28%1.04B | 0.49%1.02B | 10.08%4.41B | 2.62%1.1B |
Other operating expenses | ---- | ---- | ---- | 38.29%-195M | ---- | ---- | ---- | ---- | 19.59%-316M | ---- |
Operating profit | 65.08%1.77B | 49.92%1.86B | 50.55%1.64B | 40.77%4.97B | 11.98%1.57B | 11.18%1.07B | 92.26%1.24B | 109.65%1.09B | 13.57%3.53B | 82.55%1.4B |
Net non-operating interest income expense | -15.13%202M | 24.66%278M | 22.17%248M | 55.70%928M | 41.94%264M | 46.91%238M | 74.22%223M | 69.17%203M | 45.37%596M | 102.17%186M |
Non-operating interest income | 9.52%299M | 14.72%304M | 17.30%278M | 47.96%1.05B | 23.66%277M | 46.77%273M | 75.50%265M | 58.00%237M | 34.15%711M | 83.61%224M |
Non-operating interest expense | 177.14%97M | -38.10%26M | -11.76%30M | 7.83%124M | -65.79%13M | 45.83%35M | 82.61%42M | 13.33%34M | -4.17%115M | 26.67%38M |
Other net income (expense) | -20.47%101M | 22.86%86M | -64.10%28M | -40.82%145M | 39.53%-130M | 8.55%127M | -71.07%70M | -22.77%78M | 118.75%245M | -3.37%-215M |
Gain on sale of security | ---- | ---- | ---- | -79.17%10M | ---- | ---- | ---- | ---- | -60.33%48M | ---- |
Earnings from equity interest | -40.82%29M | 42.11%54M | -190.00%-18M | 234.21%127M | 25.00%20M | 512.50%49M | 733.33%38M | 0.00%20M | 180.85%38M | 1,500.00%16M |
Special income (charges) | ---- | ---- | ---- | -113.48%-19M | ---- | ---- | ---- | ---- | 1,662.50%141M | ---- |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | 97.16%-4M | ---- | ---- | ---- | ---- | -1,662.50%-141M | ---- |
-Write off | ---- | ---- | ---- | --23M | ---- | ---- | ---- | ---- | --0 | ---- |
Other non- operating income (expenses) | -7.69%72M | 0.00%32M | -20.69%46M | 50.00%27M | 66.43%-141M | -28.44%78M | -87.10%32M | -28.40%58M | -40.00%18M | -24.26%-420M |
Income before tax | 44.27%2.08B | 45.02%2.23B | 39.80%1.91B | 38.23%6.05B | 24.11%1.7B | 15.58%1.44B | 51.08%1.54B | 84.98%1.37B | 20.40%4.37B | 110.58%1.37B |
Income tax | 108.52%367M | 131.02%432M | 128.14%381M | 54.49%825M | 75.60%295M | 15.79%176M | 50.81%187M | 85.56%167M | 28.06%534M | 124.00%168M |
Net income | 35.31%1.71B | 33.09%1.79B | 27.50%1.53B | 35.97%5.22B | 16.93%1.41B | 15.55%1.26B | 51.12%1.35B | 84.90%1.2B | 19.41%3.84B | 108.84%1.21B |
Net income continuous Operations | 35.31%1.71B | 33.09%1.79B | 27.50%1.53B | 35.97%5.22B | 16.93%1.41B | 15.55%1.26B | 51.12%1.35B | 84.90%1.2B | 19.41%3.84B | 108.84%1.21B |
Minority interest income | 32.63%126M | 124.00%112M | 107.69%108M | 85.19%300M | 90.74%103M | 196.88%95M | 38.89%50M | 30.00%52M | -12.90%162M | 31.71%54M |
Net income attributable to the parent company | 35.53%1.58B | 29.58%1.68B | 23.87%1.42B | 33.80%4.92B | 13.47%1.31B | 10.08%1.17B | 51.64%1.3B | 88.51%1.15B | 21.39%3.68B | 114.74%1.15B |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 35.53%1.58B | 29.58%1.68B | 23.87%1.42B | 33.80%4.92B | 13.47%1.31B | 10.08%1.17B | 51.64%1.3B | 88.51%1.15B | 21.39%3.68B | 114.74%1.15B |
Basic earnings per share | 37.84%1.02 | 28.57%1.08 | 24.32%0.92 | 37.39%3.16 | 13.51%0.84 | 12.12%0.74 | 55.56%0.84 | 94.74%0.74 | 26.37%2.3 | 131.25%0.74 |
Diluted earnings per share | 35.14%1 | 31.71%1.08 | 27.78%0.92 | 35.96%3.1 | 16.67%0.84 | 12.12%0.74 | 57.69%0.82 | 100.00%0.72 | 26.67%2.28 | 125.00%0.72 |
Dividend per share | 0 | 0.9734 | ||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |